Aquestive was founded over 20 years ago on the promise of PharmFilm, our patented drug delivery method that enables precise oral delivery of almost any active pharmaceutical ingredient (API). PharmFilm isn’t just the technology behind two of our pipeline candidates—it’s also utilized by our strategic licensees who commercialize millions of doses of PharmFilm every year.

The AdrenaVerse™ platform contains a library of over 20 epinephrine prodrugs that demonstrate control of absorption and conversion rates across a variety of dosage forms including lotions, creams, and ointments (LCOs) and delivery sites. The AdrenaVerse platform enables us to pursue a variety of allergy and dermatological indications.

PharmFilm® is a unique and versatile technology for high-performance drug delivery. A small, postage-stamp sized film is taken orally, allowing for fast absorption of the active ingredient without the need for water or liquids. All routes of administration allow for direct entry into the bloodstream, without needles, pills, or injections. PharmFilm strip packaging is resistant to water, extremely durable, and allows for on-the-go convenience.



Meet the people who lead Aquestive.
Visit the portal to view clinical trial data and posters.
View the status of product candidates and access clinical trial data.
View the most recent press releases.